Baidu
map

过敏原检测结果为何与过敏症状不一致

2019-06-12 佚名 检验医学网

在临床上很多皮肤病的发生与发展都与接触了过敏原有关。而临床上多数过敏性疾病的患者通常只是做缓解症状的治疗,而没有找到引发过敏的真正原因,因而也就做不到针对性的预防和治疗,导致病情反复加重、迁延不愈。因而建议经常过敏的患者,一定要做一下过敏原筛查检测,查清楚到底是接触性的、食入性的还是吸入性的过敏原引起的过敏反应,以便从根本上解决问题。千万不要把过敏当成小毛病而忽略了检查和治疗,最终导致严重的后


基本概念

临床上很多皮肤病的发生与发展都与接触了过敏原有关。而临床上多数过敏性疾病的患者通常只是做缓解症状的治疗,而没有找到引发过敏的真正原因,因而也就做不到针对性的预防和治疗,导致病情反复加重、迁延不愈。因而建议经常过敏的患者,一定要做一下过敏原筛查检测,查清楚到底是接触性的、食入性的还是吸入性的过敏原引起的过敏反应,以便从根本上解决问题。千万不要把过敏当成小毛病而忽略了检查和治疗,最终导致严重的后果。

采用酶免疫法快速、准确、无痛检测过敏原。该方法可对患者血清或血浆中的过敏源(总IgE、总IgG、特异性IgE等)进行定性和定量检测。IVT用于检测IgE介导的速发型过敏反应,速发型的过敏反应有明显的季节性,发病时间短、发病率高。该试验解决了常规皮肤试验在I型变态反应病人发作期不宜检测过敏原的难点。FIgG用于检测迟发型的过敏反应。该反应主要与食物有关,即食物不耐受。表现为接触过敏原几天或一周后才出现相关症状。这些过敏反应常因症状滞后而被误诊,临床表现为各系统的慢性症状。如长期病因不明,反复发作,久治不愈,建议应查食物IgG。

现在,患过敏性疾病的人在增多,到医院进行过敏原检测的患者也越来越多。但是,并不是所有的患者对检测结果都满意,王先生就曾经对检测结果产生过很大疑惑。原来,王先生吃海鲜后发生过荨麻疹,当时医生告诉他是海鲜过敏,从此他不敢再吃海鲜了。后来,他到医院做了过敏原检测,想看看自己到底对哪些食物过敏。检测的结果让他吃惊:他对海鲜并不过敏但对鸡蛋过敏,可是他吃鸡蛋并没有不舒服的感觉。这到底是怎么回事呢?难道是检测结果错了吗?

检测出对某种食物过敏,并非一定不能食用

其实,检测结果并没有错,主要问题是如何解释这一结果。首先,检测的是患者是否对某种过敏原存在致敏,并不能证明患者所患疾病是由该过敏原引起的。有的患者进行过敏原检测后发现对很多种食物都过敏,结果不敢吃所有检查出过敏的食物,这是不对的。

因为检测出的过敏原是否有意义,还需要医生根据每位患者的情况具体分析才能作出合理判断。比如王先生虽然检测出对鸡蛋过敏,但是没有任何症状,患荨麻疹前后吃鸡蛋也一直没有反应,可以肯定鸡蛋过敏不是王先生患荨麻疹的原因。那么怎么会检测出鸡蛋过敏呢?

医学研究早就发现,过敏是机体对过敏原产生的一种异常免疫反应。这种反应只在少数敏感的个体中发生,大多数人并不会发生。

而机体一旦致敏,这种状态将终身存在。比如某人曾经发生过染发过敏,以后虽然不再染发,做过敏原检测时仍然会发现他对染发剂过敏。王先生应该也是在长期吃鸡蛋的过程中对鸡蛋致敏了。

但是,致敏以后是否发生临床症状,还与机体的免疫机能状态、是否合并其他疾病、是否应用了抑制免疫机能的药物或抗过敏药物等因素有关。更重要的是,在长期少量吃鸡蛋的过程中,有些人可以产生对鸡蛋耐受的现象,从而平安食用,不会出现任何症状。

过敏原检测为阴性的食物,也可能导致过敏反应

那么,为什么王先生吃海鲜后发生荨麻疹,而过敏原检测他对海鲜并不过敏呢?这种情况最大的可能是假过敏反应。医学研究已经证明许多食物,如海鲜、肉、蛋、蘑菇、草莓、茄子、竹笋、菠菜、苹果、李子以及食品添加剂,如酵母、水杨酸、柠檬酸等均可以直接促进机体肥大细胞脱颗粒,结果产生与过敏反应非常类似甚至完全相同的症状。

但是这种反应并不是真正的过敏反应,所以做过敏原检测时查不到过敏原。这种假过敏反应的重复性不高,并不是每次吃都会发生反应。

而过敏反应则不同,机体一旦致敏,以后哪怕遇到非常微量的过敏原也可能发生反应。除了假过敏反应外,不新鲜的海鲜尤其是虾和螃蟹,本身就含有一些胺类物质,可以导致皮肤发红、瘙痒等过敏症状,经常被医生或患者认为是过敏。这种情况过敏原检测自然也是查不到的。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2083703, encodeId=9d892083e0347, content=<a href='/topic/show?id=685862555f0' target=_blank style='color:#2F92EE;'>#检测结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62555, encryptionId=685862555f0, topicName=检测结果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Thu Aug 22 07:11:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2037494, encodeId=a464203e494c2, content=<a href='/topic/show?id=d4189406ec0' target=_blank style='color:#2F92EE;'>#过敏症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94067, encryptionId=d4189406ec0, topicName=过敏症状)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Thu Dec 19 02:11:00 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442626, encodeId=56db1442626dd, content=<a href='/topic/show?id=625194032a5' target=_blank style='color:#2F92EE;'>#过敏原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94032, encryptionId=625194032a5, topicName=过敏原)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81884942400, createdName=12498cb5m14暂无昵称, createdTime=Fri Jun 14 14:11:00 CST 2019, time=2019-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516459, encodeId=058c151645963, content=<a href='/topic/show?id=0c06940668a' target=_blank style='color:#2F92EE;'>#过敏症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94066, encryptionId=0c06940668a, topicName=过敏症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def310968681, createdName=ms1948154235210413, createdTime=Fri Jun 14 14:11:00 CST 2019, time=2019-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367676, encodeId=ed8e36e6764d, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqYPFHuMA3bhYQrHvycmum7IJoCsLK0FP6X56Eoj9PZAECDke8zLCKxZZvk9q7B6rZmPuFgN5YCfw/132, createdBy=00912551888, createdName=12543c13m83暂无昵称, createdTime=Thu Jun 13 07:20:59 CST 2019, time=2019-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367669, encodeId=768136e669ce, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Thu Jun 13 05:51:18 CST 2019, time=2019-06-13, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2083703, encodeId=9d892083e0347, content=<a href='/topic/show?id=685862555f0' target=_blank style='color:#2F92EE;'>#检测结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62555, encryptionId=685862555f0, topicName=检测结果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Thu Aug 22 07:11:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2037494, encodeId=a464203e494c2, content=<a href='/topic/show?id=d4189406ec0' target=_blank style='color:#2F92EE;'>#过敏症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94067, encryptionId=d4189406ec0, topicName=过敏症状)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Thu Dec 19 02:11:00 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442626, encodeId=56db1442626dd, content=<a href='/topic/show?id=625194032a5' target=_blank style='color:#2F92EE;'>#过敏原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94032, encryptionId=625194032a5, topicName=过敏原)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81884942400, createdName=12498cb5m14暂无昵称, createdTime=Fri Jun 14 14:11:00 CST 2019, time=2019-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516459, encodeId=058c151645963, content=<a href='/topic/show?id=0c06940668a' target=_blank style='color:#2F92EE;'>#过敏症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94066, encryptionId=0c06940668a, topicName=过敏症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def310968681, createdName=ms1948154235210413, createdTime=Fri Jun 14 14:11:00 CST 2019, time=2019-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367676, encodeId=ed8e36e6764d, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqYPFHuMA3bhYQrHvycmum7IJoCsLK0FP6X56Eoj9PZAECDke8zLCKxZZvk9q7B6rZmPuFgN5YCfw/132, createdBy=00912551888, createdName=12543c13m83暂无昵称, createdTime=Thu Jun 13 07:20:59 CST 2019, time=2019-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367669, encodeId=768136e669ce, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Thu Jun 13 05:51:18 CST 2019, time=2019-06-13, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2083703, encodeId=9d892083e0347, content=<a href='/topic/show?id=685862555f0' target=_blank style='color:#2F92EE;'>#检测结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62555, encryptionId=685862555f0, topicName=检测结果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Thu Aug 22 07:11:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2037494, encodeId=a464203e494c2, content=<a href='/topic/show?id=d4189406ec0' target=_blank style='color:#2F92EE;'>#过敏症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94067, encryptionId=d4189406ec0, topicName=过敏症状)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Thu Dec 19 02:11:00 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442626, encodeId=56db1442626dd, content=<a href='/topic/show?id=625194032a5' target=_blank style='color:#2F92EE;'>#过敏原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94032, encryptionId=625194032a5, topicName=过敏原)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81884942400, createdName=12498cb5m14暂无昵称, createdTime=Fri Jun 14 14:11:00 CST 2019, time=2019-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516459, encodeId=058c151645963, content=<a href='/topic/show?id=0c06940668a' target=_blank style='color:#2F92EE;'>#过敏症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94066, encryptionId=0c06940668a, topicName=过敏症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def310968681, createdName=ms1948154235210413, createdTime=Fri Jun 14 14:11:00 CST 2019, time=2019-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367676, encodeId=ed8e36e6764d, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqYPFHuMA3bhYQrHvycmum7IJoCsLK0FP6X56Eoj9PZAECDke8zLCKxZZvk9q7B6rZmPuFgN5YCfw/132, createdBy=00912551888, createdName=12543c13m83暂无昵称, createdTime=Thu Jun 13 07:20:59 CST 2019, time=2019-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367669, encodeId=768136e669ce, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Thu Jun 13 05:51:18 CST 2019, time=2019-06-13, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2083703, encodeId=9d892083e0347, content=<a href='/topic/show?id=685862555f0' target=_blank style='color:#2F92EE;'>#检测结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62555, encryptionId=685862555f0, topicName=检测结果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Thu Aug 22 07:11:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2037494, encodeId=a464203e494c2, content=<a href='/topic/show?id=d4189406ec0' target=_blank style='color:#2F92EE;'>#过敏症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94067, encryptionId=d4189406ec0, topicName=过敏症状)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Thu Dec 19 02:11:00 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442626, encodeId=56db1442626dd, content=<a href='/topic/show?id=625194032a5' target=_blank style='color:#2F92EE;'>#过敏原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94032, encryptionId=625194032a5, topicName=过敏原)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81884942400, createdName=12498cb5m14暂无昵称, createdTime=Fri Jun 14 14:11:00 CST 2019, time=2019-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516459, encodeId=058c151645963, content=<a href='/topic/show?id=0c06940668a' target=_blank style='color:#2F92EE;'>#过敏症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94066, encryptionId=0c06940668a, topicName=过敏症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def310968681, createdName=ms1948154235210413, createdTime=Fri Jun 14 14:11:00 CST 2019, time=2019-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367676, encodeId=ed8e36e6764d, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqYPFHuMA3bhYQrHvycmum7IJoCsLK0FP6X56Eoj9PZAECDke8zLCKxZZvk9q7B6rZmPuFgN5YCfw/132, createdBy=00912551888, createdName=12543c13m83暂无昵称, createdTime=Thu Jun 13 07:20:59 CST 2019, time=2019-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367669, encodeId=768136e669ce, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Thu Jun 13 05:51:18 CST 2019, time=2019-06-13, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2083703, encodeId=9d892083e0347, content=<a href='/topic/show?id=685862555f0' target=_blank style='color:#2F92EE;'>#检测结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62555, encryptionId=685862555f0, topicName=检测结果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Thu Aug 22 07:11:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2037494, encodeId=a464203e494c2, content=<a href='/topic/show?id=d4189406ec0' target=_blank style='color:#2F92EE;'>#过敏症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94067, encryptionId=d4189406ec0, topicName=过敏症状)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Thu Dec 19 02:11:00 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442626, encodeId=56db1442626dd, content=<a href='/topic/show?id=625194032a5' target=_blank style='color:#2F92EE;'>#过敏原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94032, encryptionId=625194032a5, topicName=过敏原)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81884942400, createdName=12498cb5m14暂无昵称, createdTime=Fri Jun 14 14:11:00 CST 2019, time=2019-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516459, encodeId=058c151645963, content=<a href='/topic/show?id=0c06940668a' target=_blank style='color:#2F92EE;'>#过敏症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94066, encryptionId=0c06940668a, topicName=过敏症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def310968681, createdName=ms1948154235210413, createdTime=Fri Jun 14 14:11:00 CST 2019, time=2019-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367676, encodeId=ed8e36e6764d, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqYPFHuMA3bhYQrHvycmum7IJoCsLK0FP6X56Eoj9PZAECDke8zLCKxZZvk9q7B6rZmPuFgN5YCfw/132, createdBy=00912551888, createdName=12543c13m83暂无昵称, createdTime=Thu Jun 13 07:20:59 CST 2019, time=2019-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367669, encodeId=768136e669ce, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Thu Jun 13 05:51:18 CST 2019, time=2019-06-13, status=1, ipAttribution=)]
    2019-06-13 12543c13m83暂无昵称

    谢谢分享

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2083703, encodeId=9d892083e0347, content=<a href='/topic/show?id=685862555f0' target=_blank style='color:#2F92EE;'>#检测结果#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62555, encryptionId=685862555f0, topicName=检测结果)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4dfa37, createdName=huhuaidong387, createdTime=Thu Aug 22 07:11:00 CST 2019, time=2019-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2037494, encodeId=a464203e494c2, content=<a href='/topic/show?id=d4189406ec0' target=_blank style='color:#2F92EE;'>#过敏症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94067, encryptionId=d4189406ec0, topicName=过敏症状)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/4E6244DB7C1860858424437821E08291/100, createdBy=a6a52500039, createdName=ms3994565386320060, createdTime=Thu Dec 19 02:11:00 CST 2019, time=2019-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442626, encodeId=56db1442626dd, content=<a href='/topic/show?id=625194032a5' target=_blank style='color:#2F92EE;'>#过敏原#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94032, encryptionId=625194032a5, topicName=过敏原)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=81884942400, createdName=12498cb5m14暂无昵称, createdTime=Fri Jun 14 14:11:00 CST 2019, time=2019-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1516459, encodeId=058c151645963, content=<a href='/topic/show?id=0c06940668a' target=_blank style='color:#2F92EE;'>#过敏症#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94066, encryptionId=0c06940668a, topicName=过敏症)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=def310968681, createdName=ms1948154235210413, createdTime=Fri Jun 14 14:11:00 CST 2019, time=2019-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367676, encodeId=ed8e36e6764d, content=谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=156, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83eqYPFHuMA3bhYQrHvycmum7IJoCsLK0FP6X56Eoj9PZAECDke8zLCKxZZvk9q7B6rZmPuFgN5YCfw/132, createdBy=00912551888, createdName=12543c13m83暂无昵称, createdTime=Thu Jun 13 07:20:59 CST 2019, time=2019-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=367669, encodeId=768136e669ce, content=好, beContent=null, objectType=article, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6d551998554, createdName=1e1c07bdm01(暂无匿称), createdTime=Thu Jun 13 05:51:18 CST 2019, time=2019-06-13, status=1, ipAttribution=)]

相关资讯

J Med Entomol:2种不同社会经济群体房屋中的螨群评估

屋尘螨(HDM)是气源性致敏元的主要来源,然而社会经济因素以及医疗条件之间的流行病学差异在巴西南部地区还没有相关研究。最近,有研究人员评估了HDM在2种不同社会经济状态且患有过敏性哮喘或者鼻炎病人群体中的流行度,并且研究人员还分析了来自高收入和低收入家庭房屋样本的差异。螨样本在2015年7月和12月之间进行搜集。研究人员通过体视显微镜和光学显微镜对螨虫的种进行了鉴定,主要是利用了形态学的关键特征。

Asian Pac J Allergy Immunol:过敏性鼻炎的空气净化器治疗效果研究

随着过敏性鼻炎流行度的增加,室内环境管理的利用得到了越来越多的关注。最近,有研究人员评估了空气净化器作为过敏性鼻炎治疗手段的效果。研究包括了32名(年龄在25±13.5岁)且诊断为过敏性鼻炎的参与者,并且将HEPA空气净化器放置在他们的卧室4个月。在干预之前和干预的每个月,研究人员利用真空吸尘器和灰尘搜集器对灰尘样本进行搜集,并且用于过敏原种类的评估。另外,研究人员还通过静态灰尘搜集器通过沉降对灰

Ann Allergy Asthma Immunol:过敏性鼻炎病人的嗜碱性粒细胞表现出了胸腺基质淋巴生成素受体的过敏原特异性上调

过敏性鼻炎(AR)的诊断主要基于典型的鼻症状和过敏原敏化测试。然而,有时候在区分AR和非AR患者时具有难度,并且鉴定AR患者的起因性过敏原从而进行针对性的免疫治疗尤其困难。最近,有研究人员鉴定了AR病人之间的差异,使得受试者具有无症状的敏化作用(AS)和受试者没有过敏(NS)能够进行AR的诊断。研究发现,细胞因子受体因子2和它的产物-胸腺基质淋巴生成素受体(TSLPR)在过敏原刺激后的AR患者中的

J Coll Physicians Surg Pak:过敏性鼻炎患者中,常见过敏原的皮刺试验反应研究

最近,有研究人员鉴定了在过敏性鼻炎患者中,引起过敏症状的常见过敏原。研究是一个代表性的研究。包括了那些临床诊断为过敏性鼻炎的患者。研究人员对这些患者进行了皮刺试验(SPT),使用了12中常见的气源性过敏原。试验中包括了阳性对照和阴性对照,并记录了处理15分钟后的结果,并将水泡直径大于3毫米作为阳性反应。研究发现,在130名患者中,78(60%)名为男性,52(40%)名为女性。对任何一种过敏原敏感

Lancet:口服免疫疗法治疗花生过敏

研究认为,在花生过敏患者中,有高确定性证据表明,花生口服免疫治疗方案比避免过敏或安慰剂相比显著增加过敏和过敏反应风险

Clin Mol Allergy:呼吸道过敏性疾病患者的敏感性分析

组分诊断(CRD)可以对单分子过敏原进行鉴定,是许多过敏诊断单位使用的常规方法。然而,皮刺试验(SPT)仍旧是许多耳鼻喉科门诊选择的方法,因此,增加了呼吸道过敏患者不充分免疫治疗的风险。最近,有研究人员在呼吸道过敏患者中比较了由SPT和CRD确诊的敏感性情况,并探索了敏感和类型和呼吸道疾病严重度之间的关系。研究包括了101名患者。SPT获得的敏感性情况与CRD获得的一致性较差,尤其是对于尘螨变应原

Baidu
map
Baidu
map
Baidu
map